NEDD4 and breast cancer: NEDD4 is highly expressed in BC and is associated with a poor prognosis (62, 63), indicating that the Kla-NEDD4-PTEN axis may have regulatory effects in BC resistance, even if this mechanism is still unvalidated in BC.